Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases

SIMPLE SUMMARY: Metastatic disease remains one of the biggest challenges for tumor therapy. The aim of our study was the preclinical evaluation of adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cell efficacy as a possible treatment strategy for various types of bone metastatic cancers. W...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Grote, Stefan, Traub, Frank, Mittelstaet, Joerg, Seitz, Christian, Kaiser, Andrew, Handgretinger, Rupert, Schleicher, Sabine
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961358/
https://ncbi.nlm.nih.gov/pubmed/33807875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051124
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki